SCHEMBL7499805

SCHEMBL7499805

CC(C)C(C#N)(CCCN1CCN(CCCc2ccc(C#N)s2)CC1)c1ccc(C#N)s1.CC(C)C(C#N)(CCCN1CCN(CCOc2cccc(C#N)c2)CC1)c1cccs1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 3/20 0.37
HRH1 P35367 2/20 0.36
CCR3 P51677 1/20 0.36
KCNA5 P22460 1/20 0.35
ACACB O00763 1/20 0.33
HRH2 P25021 1/20 0.33
IKBKB O14920 1/20 0.32
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32
MEN1 O00255 2/20 0.32
SIGMAR1 Q99720 1/20 0.31
TBXAS1 P24557 1/20 0.31
KMT2A Q03164 1/20 0.31
GCK P35557 2/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5230681 0.90 CACNA1B (0.43) CACNA1BHRH1CCR3ACACBHRH2
SCHEMBL5229426 0.89 CACNA1B (0.44) CACNA1BHRH1CCR3KCNA5ACACB
SCHEMBL14431864 0.86 SIGMAR1 (0.34) CACNA1BCCR3SIGMAR1RAB9A
SCHEMBL14432572 0.84 KCNA5 (0.43) CACNA1BHRH1CCR3KCNA5ACACB
SCHEMBL5242024 0.83 CACNA1B (0.42) CACNA1BHRH1CCR3DRD2DRD3
SCHEMBL5241749 0.82 CACNA1B (0.48) CACNA1BHRH1KCNA5DRD2DRD3
SCHEMBL14431932 0.82 L3MBTL1 (0.45) CACNA1BHRH1CCR3MEN1KMT2A
SCHEMBL5240611 0.81 CACNA1B (0.33) CACNA1BCCR3SIGMAR1
SCHEMBL5243213 0.81 LMNA (0.50) CACNA1BMEN1KMT2A
SCHEMBL5235391 0.81 CACNA1B (0.41) CACNA1BDRD2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1254895-A1 NITROGENOUS CYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Eisai Co., Ltd. (JP) 2002-11-06 EP disclosed